Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05008835 · ClinicalTrials.gov registry record · Phase 2
Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee
A Phase 2 study, sponsored by ACADIA Pharmaceuticals.
- Terminated
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
NCT05008835 is a Phase 2 study that was terminated before completion, run by ACADIA Pharmaceuticals. The registered enrollment target is 61 participants.
The verdict
NCT05008835, a Phase 2 study, was terminated before completion, sponsored by ACADIA Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
Study Summary
To evaluate the efficacy of ACP-044 compared with placebo in the treatment of pain associated with osteoarthritis of the knee
Interventions
- DRUG Placebo
- DRUG ACP-044 Dose A
- DRUG ACP-044 Dose B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2022-11-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05008835
The ClinicalTrials.gov registry entry for NCT05008835 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ACADIA Pharmaceuticals, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT05008835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05008835 about?
NCT05008835 is a clinical study titled "Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee". To evaluate the efficacy of ACP-044 compared with placebo in the treatment of pain associated with osteoarthritis of the knee
What is the current status of trial NCT05008835?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2021-07-20. Estimated completion is 2022-11-16.
What interventions are being tested in trial NCT05008835?
The interventions under investigation include: Placebo (DRUG), ACP-044 Dose A (DRUG), ACP-044 Dose B (DRUG).
Who is sponsoring clinical trial NCT05008835?
This trial is sponsored by ACADIA Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.